Therapeutic nuclear drug market to reach $4.27 billion by 2030 at 14.3% CAGR, driven by increasing prevalence of cancer and growing adoption of targeted radiopharmaceutical therapies.
Read More
Therapeutic bcg vaccines market to reach $80.4 billion by 2030 at 6.4% CAGR, driven by rising number of tuberculosis cases worldwide increasing demand for effective immunotherapies.
Read More
Thalassemia drugs market to reach $4.11 billion by 2030 at 10.6% CAGR, driven by increasing healthcare expenditure supporting improved infrastructure and access to specialized treatments.
Read More
Tetanus Toxoid Vaccine Market Analysis Through 2030: Market Size, Growth Trends And Industry Outlook
Tetanus toxoid vaccine market to reach $7.37 billion by 2030 at 6.2% CAGR, driven by rising rate of preterm births increasing neonatal infection risk.
Read More
The Hexyon market is witnessing steady growth over the forecast period, supported by expansion of birth cohort immunization coverage, growth in emerging market vaccination programs.
Read More
The Heplisav-B market is witnessing steady growth over the forecast period, supported by expansion of adult vaccination mandates, increasing focus on diabetic and liver disease patients.
Read More
The Hepagam B market is witnessing steady growth over the forecast period, supported by strengthening public health policies, rising healthcare worker safety measures.
Read More
The Hemofil M market is witnessing steady growth over the forecast period, supported by expansion of hemophilia registries, growth in emerging market treatment access.
Read More
The Hemlibra market is witnessing steady growth over the forecast period, supported by growing global hemophilia population, expansion of home based treatment models.
Read More
The Flexbumin market is witnessing steady growth over the forecast period, supported by expansion of regenerative medicine applications, rising icu infrastructure investments.
Read More